Atara Biotherapeutics, Inc. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↑+5.0% +$1M
$-28M
Free Cash Flow↑+100.0% +$90K
$0
Investing Cash Flow↑+150.0% +$5M
$8M
Financing Cash Flow↓-97.1% -$35M
$1M
Capex↓-100.0% -$90K
$0
Stock-Based Comp↓-74.1% -$4M
$2M
D&A↓-95.5% -$1M
$49K
SBC Allocated Expense↓-74.1% -$4M
$2M